Cargando…
The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management
The 2019 coronavirus disease (COVID-19) presents with a large variety of clinical manifestations ranging from asymptomatic carrier state to severe respiratory distress, multiple organ dysfunction and death. While it was initially considered primarily a respiratory illness, rapidly accumulating data...
Autores principales: | Abou-Ismail, Mouhamed Yazan, Diamond, Akiva, Kapoor, Sargam, Arafah, Yasmin, Nayak, Lalitha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7305763/ https://www.ncbi.nlm.nih.gov/pubmed/32788101 http://dx.doi.org/10.1016/j.thromres.2020.06.029 |
Ejemplares similares
-
Corrigendum to “The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management” [Thromb. Res., 194, October 2020, Pages 101–115]
por: Abou-Ismail, Mouhamed Yazan, et al.
Publicado: (2021) -
Thrombotic microangiopathies: An illustrated review
por: Abou‐Ismail, Mouhamed Yazan, et al.
Publicado: (2022) -
Outcomes of Immune Thrombotic Thrombocytopenic Purpura (iTTP) With Upfront Cyclophosphamide vs. Rituximab
por: Abou-Ismail, Mouhamed Yazan, et al.
Publicado: (2020) -
HYPERCOAGULABLE STATE: AN ENIGMA IN COVID-19 INFECTION
por: MILI, SAIMA, et al.
Publicado: (2021) -
The Bone Cement Hypercoagulation Syndrome: Pathophysiology, Mortality,
and Prevention
por: Dahl, Ola E., et al.
Publicado: (2023)